These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 27342081)
1. Aberrant adenosine A2A receptor signaling contributes to neurodegeneration and cognitive impairments in a mouse model of synucleinopathy. Hu Q; Ren X; Liu Y; Li Z; Zhang L; Chen X; He C; Chen JF Exp Neurol; 2016 Sep; 283(Pt A):213-23. PubMed ID: 27342081 [TBL] [Abstract][Full Text] [Related]
2. Adenosine A Hu Q; Xu L; Liu X; Wang Y; Yuan J Neurosci Lett; 2024 Mar; 826():137610. PubMed ID: 38157926 [TBL] [Abstract][Full Text] [Related]
3. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia. Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690 [TBL] [Abstract][Full Text] [Related]
7. Adenosine A Chen PZ; He WJ; Zhu ZR; E GJ; Xu G; Chen DW; Gao YQ Behav Brain Res; 2018 Jul; 347():99-107. PubMed ID: 29501623 [TBL] [Abstract][Full Text] [Related]
8. Neuronal Adenosine A2A Receptors Are Critical Mediators of Neurodegeneration Triggered by Convulsions. Canas PM; Porciúncula LO; Simões AP; Augusto E; Silva HB; Machado NJ; Gonçalves N; Alfaro TM; Gonçalves FQ; Araújo IM; Real JI; Coelho JE; Andrade GM; Almeida RD; Chen JF; Köfalvi A; Agostinho P; Cunha RA eNeuro; 2018; 5(6):. PubMed ID: 30627646 [TBL] [Abstract][Full Text] [Related]
9. α-Synuclein Selectively Impairs Motor Sequence Learning and Value Sensitivity: Reversal by the Adenosine A2A Receptor Antagonists. He Y; Huang L; Wang K; Pan X; Cai Q; Zhang F; Yang J; Fang G; Zhao X; You F; Feng Y; Li Y; Chen JF Cereb Cortex; 2022 Feb; 32(4):808-823. PubMed ID: 34339491 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy. El-Agnaf O; Overk C; Rockenstein E; Mante M; Florio J; Adame A; Vaikath N; Majbour N; Lee SJ; Kim C; Masliah E; Rissman RA Neurobiol Dis; 2017 Aug; 104():85-96. PubMed ID: 28476636 [TBL] [Abstract][Full Text] [Related]
11. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Volpicelli-Daley LA; Luk KC; Patel TP; Tanik SA; Riddle DM; Stieber A; Meaney DF; Trojanowski JQ; Lee VM Neuron; 2011 Oct; 72(1):57-71. PubMed ID: 21982369 [TBL] [Abstract][Full Text] [Related]
12. Clioquinol Improves Cognitive, Motor Function, and Microanatomy of the Alpha-Synuclein hA53T Transgenic Mice. Finkelstein DI; Hare DJ; Billings JL; Sedjahtera A; Nurjono M; Arthofer E; George S; Culvenor JG; Bush AI; Adlard PA ACS Chem Neurosci; 2016 Jan; 7(1):119-29. PubMed ID: 26481462 [TBL] [Abstract][Full Text] [Related]
13. Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia. Matos M; Shen HY; Augusto E; Wang Y; Wei CJ; Wang YT; Agostinho P; Boison D; Cunha RA; Chen JF Biol Psychiatry; 2015 Dec; 78(11):763-74. PubMed ID: 25869810 [TBL] [Abstract][Full Text] [Related]
14. Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils. Patterson JR; Duffy MF; Kemp CJ; Howe JW; Collier TJ; Stoll AC; Miller KM; Patel P; Levine N; Moore DJ; Luk KC; Fleming SM; Kanaan NM; Paumier KL; El-Agnaf OMA; Sortwell CE Neurobiol Dis; 2019 Oct; 130():104525. PubMed ID: 31276792 [TBL] [Abstract][Full Text] [Related]
15. Modeling α-Synucleinopathy in Organotypic Brain Slice Culture with Preformed α-Synuclein Amyloid Fibrils. Roux A; Wang X; Becker K; Ma J J Parkinsons Dis; 2020; 10(4):1397-1410. PubMed ID: 32716318 [TBL] [Abstract][Full Text] [Related]
16. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208 [TBL] [Abstract][Full Text] [Related]
17. Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice. Marxreiter F; Ettle B; May VE; Esmer H; Patrick C; Kragh CL; Klucken J; Winner B; Riess O; Winkler J; Masliah E; Nuber S Neurobiol Dis; 2013 Nov; 59():38-51. PubMed ID: 23867236 [TBL] [Abstract][Full Text] [Related]
18. Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression. Bourdenx M; Dovero S; Engeln M; Bido S; Bastide MF; Dutheil N; Vollenweider I; Baud L; Piron C; Grouthier V; Boraud T; Porras G; Li Q; Baekelandt V; Scheller D; Michel A; Fernagut PO; Georges F; Courtine G; Bezard E; Dehay B Acta Neuropathol Commun; 2015 Jul; 3():46. PubMed ID: 26205255 [TBL] [Abstract][Full Text] [Related]
19. Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson's disease. Jakova E; Moutaoufik MT; Lee JS; Babu M; Cayabyab FS Transl Neurodegener; 2022 Feb; 11(1):9. PubMed ID: 35139916 [TBL] [Abstract][Full Text] [Related]
20. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Laurent C; Burnouf S; Ferry B; Batalha VL; Coelho JE; Baqi Y; Malik E; Mariciniak E; Parrot S; Van der Jeugd A; Faivre E; Flaten V; Ledent C; D'Hooge R; Sergeant N; Hamdane M; Humez S; Müller CE; Lopes LV; Buée L; Blum D Mol Psychiatry; 2016 Jan; 21(1):97-107. PubMed ID: 25450226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]